RETA Reata Pharmaceuticals Inc

For the fiscal year ended 31/12/2022: Reata Pharmaceuticals Inc's revenues decreased by 80.71% and amounted to 2.22M. Net income decreased by 4.88% to -311.90M. Net assets decreased by 135.32% to -65.70M and EPS decreased from -8.19 to -8.54.